← Browse by Condition
Medical Condition

critically ill

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for critically ill sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — critically ill Clinical Trials

How many clinical trials are currently recruiting for critically ill?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for critically ill, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for critically ill?
critically ill research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a critically ill clinical trial?
Eligibility criteria for critically ill trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Cairo University 1 trial
University of Ulm 1 trial
Duke University 1 trial
Universität Münster 1 trial

Recruiting Clinical Trials

NCT07143695
Recruiting
Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion
Enrollment
200 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT03044223
Recruiting
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Enrollment
100 pts
Location
Germany
Sponsor
University of Ulm
View Trial →
NCT05055830
Recruiting
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Enrollment
2,000 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT05830669
Recruiting
Remote Ischemic Preconditioning in Septic Patients
Enrollment
64 pts
Location
Germany
Sponsor
Universität Münster
View Trial →

Related Conditions

sepsis (2) pseudomonas infections (1) pseudomonas septicemia (1) pseudomonas pneumonia (1) pseudomonal bacteraemia (1) pseudomonas urinary tract infection (1) pseudomonas gastrointestinal tract infection (1) sepsis severe (1) cardiac disease (1) children adult (1) acute kidney injury (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology